CoChat

What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future

Open access
KRAVITZ, RICHARD L., DUAN, NAIHUA, NIEDZINSKI, EDMUND J., HAY, M. CAMERON, SUBRAMANIAN, SASKIA K., WEISNER, THOMAS S. · 2008 · The Milbank Quarterly
Cited by 97

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Context:When feasible, randomized, blinded single‐patient (n‐of‐1) trials are uniquely capable of establishing the best treatment in an individual patient. Despite early enthusiasm, by the turn of the twenty‐first century, few academic centers were conducting n‐of‐1 trials on a regular basis. Methods:The authors reviewed the literature and conducted in‐depth telephone interviews with leaders in the n‐of‐1 trial movement. Findings:N‐of‐1 trials can improve care by increasing therapeutic precision. However, they have not been widely adopted, in part because physicians do not sufficiently value the reduction in uncertainty they yield weighed against the inconvenience they impose. Limited evidence suggests that patients may be receptive to n‐of‐1 trials once they understand the benefits. Conclusions:N‐of‐1 trials offer a unique opportunity to individualize clinical care and enrich clinical research. While ongoing changes in drug discovery, manufacture, and marketing may ultimately spur pharmaceutical makers and health care payers to support n‐of‐1 trials, at present the most promising resuscitation strategy is stripping n‐of‐1 trials to their essentials and marketing them directly to patients. In order to optimize statistical inference from these trials, empirical Bayes methods can be used to combine individual patient data with aggregate data from comparable patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-0009.2008.00533.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 97

Metadata

Authors
KRAVITZ, R. L., DUAN, N., NIEDZINSKI, E. J., HAY, M. C., SUBRAMANIAN, S. K., & WEISNER, T. S.
Venue
The Milbank Quarterly
Publisher
Wiley
Published
2008-11-21
Volume
86
Issue
4
Pages
533-555
ISSN
  • 0887-378X (ISSN-L)
  • 1468-0009
OpenAlex
W2086940034
Cited by
97
References
2
FWCI
2.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future. https://app.cochat.ai/papers/10.1111/j.1468-0009.2008.00533.x
The paper
KRAVITZ, R. L., DUAN, N., NIEDZINSKI, E. J., HAY, M. C., SUBRAMANIAN, S. K., & WEISNER, T. S. (2008). What Ever Happened to N‐of‐1 Trials? Insiders' Perspectives and a Look to the Future. The Milbank Quarterly. https://doi.org/10.1111/j.1468-0009.2008.00533.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.